KDR
01-09-2013, 03:02 PM
www.nccn.org (http://www.nccn.org)
Great news for larger institutions. Perjeta will now be available and covered on a much wider basis as per latest reviews.
Combine this with the upcoming approval of T-DM1 and another world opens up for those waiting, not just for first-line therapy.
Happy New Year.
Karen
Great news for larger institutions. Perjeta will now be available and covered on a much wider basis as per latest reviews.
Combine this with the upcoming approval of T-DM1 and another world opens up for those waiting, not just for first-line therapy.
Happy New Year.
Karen